Abstract:Despite bariatric surgery's success for most patients, up to 30 % do not experience optimal weight loss outcomes. Post-surgery weight loss outcomes are influenced by a complex interplay of factors that remain incompletely understood. Novel hypotheses are needed to identify putative predictors of suboptimal post-bariatric weight loss. Thyroid hormones, due to their important role in energy expenditure, have received study though research to date has not established clear associations between post-surgical weight loss and changes in standard thyroid markers. In contrast, research consistently documents a pattern similar to euthyroid sick syndrome (ESS) during severe caloric deprivation or fasting. ESS, an established response to periods of stress (e.g., critical illness, infection, famine) is believed to serve a protective function by suppressing metabolism and conserving weight. Defining features of ESS are: 1) TSH levels within normal range; 2) abnormally low levels of the metabolically active form of thyroid hormone, or free triiodothyronine (FT 3 ); 3) abnormally high levels of the metabolically inactive reverse 3,3′,5′-triiodothyronine (rT 3 ); and 4) abnormally low ratios of FT 3 to rT 3 . Low FT 3 /rT 3 ratio levels significantly predict survival outcomes in ESS. We present the novel hypothesis that: 1) severe hypocaloric dieting during the early post-surgical period may trigger an ESS-like syndrome; 2) development of ESS will be signaled by a decrease in the FT 3 /rT 3 ratio; and 3) early decreases in the FT 3 /rT 3 ratio will be associated with reduced weight loss at standard 1- and 2-year post-surgical follow-up visits. To examine whether preliminary data might support our hypothesis, we undertook a small exploratory study by collecting TSH, FT 4 , FT 3 , rT 3 , and hypothyroid symptoms from adult patients undergoing Roux-en-Y gastric bypass (n = 12) or sleeve gastrectomy (n = 11). Body mass index was measured pre-surgery and 1- and 2-years post-surgery. Results showed reductions in the FT 3 :rT 3 ratio from pre- to early post-surgery significantly predicted reduced weight loss at 1 (p = 0.03) and 2 years (p = 0.02) post-surgery. No other thyroid-related markers nor symptoms were predictive. Replication with larger samples is needed, especially given our sizeable attrition at 1- and 2-year follow-up. In conclusion, our hypothesis that markers of ESS during the early post-surgical period would predict reduced longer-term weight loss was supported. If replicated in future, larger investigations, a practical application of this hypothesis-generating paper involves using the FT 3 :rT 3 ratio to identify post-bariatric patients at risk for longer-term suboptimal weight loss, potentially opening a key therapeutic window for therapeutic intervention (e.g., T 3 repletion).

Thyroid-stimulating hormone levels in euthyroid patients 8 years following bariatric surgery

Total weight loss induces the alteration in thyroid function after bariatric surgery

Effect of Weight Loss after Bariatric Surgery on Thyroid-Stimulating Hormone Levels in Patients with Morbid Obesity and Normal Thyroid Function

Thyroid function before and after Roux-en-Y gastric bypass: an observational study

Thyroid Hormone Replacement Dosing after Bariatric Surgery in Patients with Primary Hypothyroidism And Severe Obesity: Tehran Obesity Treatment Study

Decreased Leptin Is Associated With Alterations In Thyroid-Stimulating Hormone Levels After Roux-En-Y Gastric Bypass Surgery In Obese Euthyroid Patients With Type 2 Diabetes

Preoperative Thyroid Autoimmune Status and Changes in Thyroid Function and Body Weight after Bariatric Surgery.

Effect of Sleeve Gastrectomy on Thyroid Function in Chinese Euthyroid Obese Patients.

Alterations in Thyroid Hormones in Obese Patients are Associated with Body Composition Changes after Bariatric Surgery

Laparoscopic Gastric Bypass in Patients on Thyroid Replacement Therapy for Subnormal Thyroid Function – Prevalence and Short-Term Outcome

Changes in thyroid hormones predict weight regain in patients with obesity who undergo metabolic surgery

Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery

Outcome of bariatric surgery on hypothyroidism: experience from a tertiary care center in India

Thyroid Function Before and After Laparoscopic Sleeve Gastrectomy in Patients with Obesity

Do early indicators of euthyroid sick syndrome predict later post-bariatric weight loss? Exploring a novel hypothesis

Reduction in Thyroid-Stimulating Hormone Correlated with Improved Inflammation Markers in Chinese Patients with Morbid Obesity Undergoing Laparoscopic Sleeve Gastrectomy

Laparoscopic Sleeve Gastrectomy-Induced Decreases in FT3 and TSH are Related to Fasting C-Peptide in Euthyroid Patients with Obesity

Benefits in routinely measured liver function tests following bariatric surgery: a retrospective cohort study

Effect of Laparoscopic Sleeve Gastrectomy vs. OAGB on Thyroid Function Tests in Patients with Morbid Obesity and Subclinical or Clinical Hypothyroidism

Thyroid Function and Body Weight: A Community-Based Longitudinal Study

THYROID FUNCTION IMPROVED AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY IN SEVERE OBESITY AND RELATED TO INFLAMMATORY CHANGES